title: Efavirenz-induced catatonia.
authors.forename: Stefan
authors.initials: S
authors.lastname: Sabato
authors.forename: Steve
authors.initials: S
authors.lastname: Wesselingh
authors.forename: Andrew
authors.initials: A
authors.lastname: Fuller
authors.forename: John
authors.initials: J
authors.lastname: Ray
authors.forename: Anne
authors.initials: A
authors.lastname: Mijch
mesh_terms: D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D048588:Benzoxazines; D002389:Catatonia / Q000139:chemically induced*; D003521:Cyclopropanes; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D008875:Middle Aged; D010078:Oxazines / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; D018894:Reverse Transcriptase Inhibitors; C098320:efavirenz